Abstract
To determine the most suitable strategy in treating patients with invasive breast cancer from Northwest China. Lower recurrence score (RS) correlated with lower recurrence ratio. Patients having a medium-high 21-gene RS who received adjuvant therapy presented lower recurrence risk. Younger patients having RS results (⩾31) tended to accept adjuvant therapy more often, however, those having intermediate RS results were inclined to wait and did not receive chemotherapy. These results suggested that RS-based precision medicine will allow individualized diagnosis and treatment, resulting in better outcomes and preserved medical resources.
Original language | English (US) |
---|---|
Pages (from-to) | 639-646 |
Number of pages | 8 |
Journal | Cancer Investigation |
Volume | 35 |
Issue number | 10 |
DOIs | |
State | Published - Nov 26 2017 |
Keywords
- 21-Gene recurrence score
- Breast cancer
- Cancer stem cells
- Recurrence risk
ASJC Scopus subject areas
- Oncology
- Cancer Research